Study of ALK-001 on the Progression of Stargardt Disease

NCT07419334 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Stargardt Disease

Interventions

DRUG: ALK-001
DRUG: Placebo

Sponsor

Alkeus Pharmaceuticals, Inc.